(209b) Understanding the Morphology and Controlled Release Potential of 3D Silk Fibroin Particle Laden Sponges to Direct Macrophage-Material Interactions | AIChE

(209b) Understanding the Morphology and Controlled Release Potential of 3D Silk Fibroin Particle Laden Sponges to Direct Macrophage-Material Interactions

Authors 

Pacheco, M. O. - Presenter, University of Florida
Stoppel, W., University of Florida
Gerzenshtein, I., University of Florida
Beshay, C., University of Florida
Biomaterials formed from the silk fibroin of Bombyx mori have proven valuable across several material formats including nano- and microparticles2, films3, and sponge-like scaffolds4. Tunable characteristics including mechanics5, degradation timelines6, and cargo release profiles7 along with strong cytocompatibility and nonthrombogenic8 behavior make silk fibroin a biopolymer well suited for applications in tissue engineering and regenerative medicine. Previous work has demonstrated that the formation of β-sheet rich crystalline domains plays a central role in dictating the material properties and function of silk materials.6 In this work, we explore how interfacing two separate silk material formats (microparticles and sponges), each with unique crystal formation processes, impacts final material morphology, degradation, controlled release, and cell-material interactions. Recent work has demonstrated the benefits of particle-based scaffolds and hydrogels over bulk materials for improvements in nutrient diffusion, cellular infiltration, and injectability9. Particles in these systems are commonly covalently crosslinked to hold together the macroscale structure. In this work, we explore the potential of incorporating silk polymer to bind the structure together through formation of physical crosslinks. By tuning the ratio of silk fibroin microparticles (SFMPs) to free aqueous silk fibroin (SF) and adjusting the method of water vapor annealing, we control the interparticle connectivity and interfacial mechanics. We demonstrate that increased free SF and increased temperature during annealing lead to increased total β-sheet crystallinity and increased sponge-like morphology (Figure 1AB). The differences in crystal structure led to tunable enzymatic degradation rates as observed through continued assessment of mechanical properties and morphological changes. As the spongy matrix is degraded, particles are then liberated (Figure 1C). This process shows promise for the local delivery of multiple cargos at different time scales. To further explore this potential, we model the transport of the system in COMSOL® to determine what dynamics of release can be achieved (co-delivery, sequential delivery, etc.) as a function of material formulation and initial particle size. We then show the effectiveness of the system by the loading of IL-4 into the SFMPs and IFN-γ into the surrounding sponge matrix and monitoring the impact of the release overtime on the phenotype of RAW 264.7 macrophages. In wound healing, the dynamic phenotype of macrophages is critical for normal tissue repair. It is advantageous to have early activation of M1 macrophages, but for proper healing the switch to an M2 phenotype is critical.10 By loading the sponge matrix with IFN-γ (an M1 stimulating cytokine) and the particles with IL-4 (an M2 stimulating cytokine), we can monitor the impact of the sequential delivery on the phenotype of the macrophages in vitro through immunohistochemistry and flow cytometry. This study helps progress toward the rational design of multi-phase silk materials with predictable delivery cascades. Future work seeks to incorporate varied cargos into this material and confirm efficacy in both in vitro and in vivo models.

References

  1. Hu X, Kaplan D, Cebe P. Determining Beta-Sheet Crystallinity in Fibrous Proteins by Thermal Analysis and Infrared Spectroscopy. Macromolecules. 2006;39(18):6161-70. doi: 10.1021/ma0610109.
  2. Pacheco MO, Lutz HM, Armada J, Davies N, Gerzenshtein IK, Cakley AS, Spiess BD, Stoppel WL. Silk Fibroin Particles as Carriers in the Development of Hemoglobin-Based Oxygen Carriers. Advanced NanoBiomed Research. 2023;3(9):2300019. doi: https://doi.org/10.1002/anbr.202300019.
  3. Luo Y, Kang KB, Sartaj R, Sun MG, Zhou Q, Guaiquil VH, Rosenblatt MI. Silk films with nanotopography and extracellular proteins enhance corneal epithelial wound healing. Scientific Reports. 2021;11(1):8168. doi: 10.1038/s41598-021-87658-1.
  4. Stoppel WL, Hu D, Domian IJ, Kaplan DL, Black LD, 3rd. Anisotropic silk biomaterials containing cardiac extracellular matrix for cardiac tissue engineering. Biomed Mater. 2015;10(3):034105. Epub 2015/04/01. doi: 10.1088/1748-6041/10/3/034105. PubMed PMID: 25826196; PMCID: PMC4417360.
  5. Rnjak-Kovacina J, Wray LS, Burke KA, Torregrosa T, Golinski JM, Huang W, Kaplan DL. Lyophilized Silk Sponges: A Versatile Biomaterial Platform for Soft Tissue Engineering. ACS Biomater Sci Eng. 2015;1(4):260-70. Epub 2015/05/20. doi: 10.1021/ab500149p. PubMed PMID: 25984573; PMCID: PMC4426347.
  6. Jameson JF, Pacheco MO, Butler JE, Stoppel WL. Estimating Kinetic Rate Parameters for Enzymatic Degradation of Lyophilized Silk Fibroin Sponges. Front Bioeng Biotechnol. 2021;9:664306. Epub 2021/07/24. doi: 10.3389/fbioe.2021.664306. PubMed PMID: 34295878; PMCID: PMC8290342.
  7. Yavuz B, Chambre L, Kaplan DL. Extended release formulations using silk proteins for controlled delivery of therapeutics. Expert Opin Drug Deliv. 2019;16(7):741-56. Epub 20190701. doi: 10.1080/17425247.2019.1635116. PubMed PMID: 31220955; PMCID: PMC6642005.
  8. Adalı T, Uncu M. Silk fibroin as a non-thrombogenic biomaterial. Int J Biol Macromol. 2016;90:11-9. Epub 20160127. doi: 10.1016/j.ijbiomac.2016.01.088. PubMed PMID: 26826290.
  9. Riley L, Schirmer L, Segura T. Granular hydrogels: emergent properties of jammed hydrogel microparticles and their applications in tissue repair and regeneration. Curr Opin Biotechnol. 2019;60:1-8. Epub 20181124. doi: 10.1016/j.copbio.2018.11.001. PubMed PMID: 30481603; PMCID: PMC6534490.
  10. O'Brien EM, Risser GE, Spiller KL. Sequential drug delivery to modulate macrophage behavior and enhance implant integration. Advanced Drug Delivery Reviews. 2019;149-150:85-94. doi: https://doi.org/10.1016/j.addr.2019.05.005.


Topics